These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 9436018

  • 1. [Clinical findings of neurogenic bladder in patients with Parkinson's disease, multiple sclerosis and spinocerebellar degeneration].
    Shimizu K, Yasukawa M, Yamamoto M, Hirao Y, Momose H, Kashiwai H, Kawata Y, Yamada K.
    Hinyokika Kiyo; 1997 Nov; 43(11):765-9. PubMed ID: 9436018
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A.
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [Abstract] [Full Text] [Related]

  • 3. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP, Nishiguchi J, O'Leary M, Yoshimura N, Chancellor MB.
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [Abstract] [Full Text] [Related]

  • 4. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
    Roth B, Studer UE, Fowler CJ, Kessler TM.
    J Urol; 2009 May; 181(5):2209-13. PubMed ID: 19296974
    [Abstract] [Full Text] [Related]

  • 5. Urological manifestations of chronic schistosomal myeloradiculopathy.
    Gomes CM, Hisano M, Machado LR, Figueiredo JA, Lucon AM, Trigo-Rocha FE.
    BJU Int; 2005 Oct; 96(6):853-6. PubMed ID: 16153216
    [Abstract] [Full Text] [Related]

  • 6. Lower urinary tract dysfunction in Machado-Joseph disease: a study of 11 clinical-urodynamic observations.
    Sakakibara R, Uchiyama T, Arai K, Yamanishi T, Hattori T.
    J Neurol Sci; 2004 Mar 15; 218(1-2):67-72. PubMed ID: 14759635
    [Abstract] [Full Text] [Related]

  • 7. Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease.
    Finazzi-Agrò E, Peppe A, D'Amico A, Petta F, Mazzone P, Stanzione P, Micali F, Caltagirone C.
    J Urol; 2003 Apr 15; 169(4):1388-91. PubMed ID: 12629368
    [Abstract] [Full Text] [Related]

  • 8. Evaluation and management of the urologic consequences of neurologic disease.
    Kotkin L, Milam DF.
    Tech Urol; 1996 Apr 15; 2(4):210-9. PubMed ID: 9085542
    [Abstract] [Full Text] [Related]

  • 9. [Difference between the clinical significance of Credé voiding and Valsalva voiding in the urological management of spina bifida patients].
    Momose H, Kashiwai H, Kawata Y, Hirayama A, Hirata N, Yamada K, Yamamoto M, Hirao Y.
    Hinyokika Kiyo; 1997 Nov 15; 43(11):771-5. PubMed ID: 9436019
    [Abstract] [Full Text] [Related]

  • 10. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease.
    Kabay SC, Kabay S, Yucel M, Ozden H.
    Neurourol Urodyn; 2009 Nov 15; 28(1):62-7. PubMed ID: 18837432
    [Abstract] [Full Text] [Related]

  • 11. Spinal cord injury in children: long-term urodynamic and urological outcomes.
    Generao SE, Dall'era JP, Stone AR, Kurzrock EA.
    J Urol; 2004 Sep 15; 172(3):1092-4, discussion 1094. PubMed ID: 15311046
    [Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation in 69 cases with neurogenic bladder].
    Sasagawa M, Magome A, Kikuyama A, Kobayashi S, Kawamura K, Suzuki K, Tsugawa R.
    Hinyokika Kiyo; 1991 Feb 15; 37(2):123-8. PubMed ID: 1675545
    [Abstract] [Full Text] [Related]

  • 13. Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease.
    Stocchi F, Barbato L, Carbone A, Fabbrini G, Ruggieri S, Bonamartini A, Baffigo G, Agnoli A.
    Adv Neurol; 1993 Feb 15; 60():434-7. PubMed ID: 8420168
    [No Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
    Schurch B, de Sèze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S, Brin MF, Botox Detrusor Hyperreflexia Study Team.
    J Urol; 2005 Jul 15; 174(1):196-200. PubMed ID: 15947626
    [Abstract] [Full Text] [Related]

  • 15. Relationship of bladder dysfunction to lesion site in multiple sclerosis.
    Araki I, Matsui M, Ozawa K, Takeda M, Kuno S.
    J Urol; 2003 Apr 15; 169(4):1384-7. PubMed ID: 12629367
    [Abstract] [Full Text] [Related]

  • 16. Dysfunctional voiding in women.
    Carlson KV, Rome S, Nitti VW.
    J Urol; 2001 Jan 15; 165(1):143-7; discussion 147-8. PubMed ID: 11125384
    [Abstract] [Full Text] [Related]

  • 17. Urinary dysfunction in multiple sclerosis.
    Nakipoglu GF, Kaya AZ, Orhan G, Tezen O, Tunc H, Ozgirgin N, Ak F.
    J Clin Neurosci; 2009 Oct 15; 16(10):1321-4. PubMed ID: 19560927
    [Abstract] [Full Text] [Related]

  • 18. [Comparative assessment of combined therapy of neurogenic hyperactivity of detrusor in patients with Parkinson's disease].
    Loran OB, Fedorova NV, Mazurenko DA, Khitarishvili EV.
    Urologiia; 2006 Oct 15; (2):37-9, 41. PubMed ID: 16708587
    [Abstract] [Full Text] [Related]

  • 19. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder.
    Amarenco G, Ismael SS, Even-Schneider A, Raibaut P, Demaille-Wlodyka S, Parratte B, Kerdraon J.
    J Urol; 2003 Jun 15; 169(6):2210-5. PubMed ID: 12771752
    [Abstract] [Full Text] [Related]

  • 20. [Tibial neuromodulation in the treatment of neurogenic detrusor hyperactivity in patients with Parkinson's disease].
    Krivoborodov GG, Gekht AB, Korshunova ES.
    Urologiia; 2006 Jun 15; (4):3-6. PubMed ID: 17058670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.